{"issuance_frequency":"","notes_translated":{"fr":"Contient les conseils indépendants et les recommandations du CCNI, qui reposent sur les connaissances scientifiques les plus récentes. L'objectif de fournir une orientation pour une répartition des vaccins contre la COVID-19 autorisés -- marquée au sceau de l'équité, de l'éthique et de l'efficience --, dans le contexte d'un approvisionnement en vaccins échelonné. ","en":"Contains NACI's independent advice and recommendations, which are based upon the best current available scientific knowledge. The objective is to provide guidance for the equitable, ethical, and efficient allocation of authorized COVID-19 vaccines in the context of staggered arrival of vaccine supply."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"ba73c165-9386-49b0-8a14-6dfbc0062af4","metadata_created":"2021-06-21T13:20:35.317046","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-30T18:19:52.001067","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-21","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["équité","covid-19","vaccinationprécoces","ARNm","Acide ribonucléique messager","ASPC","Agence de la santé publique du Canada","C.-B.","Colombie-Britannique","CCNI","Comité consultatif national de l'immunisation","EEFA","Éthique","faisabilité et acceptabilité","ESLD","Établissement de soins de longue durée","IC","Intervalle de confiance","PCR","Réaction de polymérisation en chaîne ; R.-U.","Royaume-Uni","TS","Travailleur de la santé","VE","Efficacité vaccinale réelle","vaccination précoces"],"en":["Ethics","equity","feasibility","covid-19","vaccines","vaccine rollout","CI","Confidence interval","EEFA","and acceptability","HCW","Health care worker","LTCF","Long-term care facility","mRNA","Messenger ribonucleic acid","NACI","National Advisory Committee on Immunization","PCR","Polymerase chain reaction","PHAC","Public Health Agency of Canada","VE","Vaccine effectiveness","British Columbia (BC)"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Allongement des intervalles entre les doses des vaccins contre la COVID-19 pour optimiser les campagnes de vaccination précoces et la protection des populations au Canada dans le contexte d’un approvisionnement limité en vaccins","en":"Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"ba73c165-9386-49b0-8a14-6dfbc0062af4","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1d1b4e3f-f0fb-4b1e-8411-f7c3e5674ea0","related_relationship":"","name_translated":{"fr":"Allongement des intervalles entre les doses des vaccins contre la COVID-19 pour les campagnes de vaccination précoces et la protection des populations au Canada : Recommandations du CCNI","en":"COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendations"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendations","language":["en"],"created":"2021-06-21T13:20:35.427592","url":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/extended-dose-intervals-covid-19-vaccines-early-rollout-population-protection.html","last_modified":null,"position":0,"revision_id":"07371d6b-f544-4fbd-af67-5414efb35f9b","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"ba73c165-9386-49b0-8a14-6dfbc0062af4","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b0ba06c0-26c3-48a6-9cdf-fd8b4abb0d9f","related_relationship":"","name_translated":{"fr":"Allongement des intervalles entre les doses des vaccins contre la COVID-19 pour les campagnes de vaccination précoces et la protection des populations au Canada : Recommandations du CCNI","en":"COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendations"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"COVID-19 vaccine extended dose intervals for early vaccine rollout and population protection in Canada: NACI recommendations","language":["fr"],"created":"2021-06-21T13:20:35.427598","url":"https://www.canada.ca/fr/sante-publique/services/immunisation/comite-consultatif-national-immunisation-ccni/allongement-intervalles-doses-vaccins-covid-19-campagnes-precoces-protection-population.html","last_modified":null,"position":1,"revision_id":"07371d6b-f544-4fbd-af67-5414efb35f9b","resource_type":"website"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-04-14 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"ba73c165-9386-49b0-8a14-6dfbc0062af4","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Contains NACI's independent advice and recommendations, which are based upon the best current available scientific knowledge. The objective is to provide guidance for the equitable, ethical, and efficient allocation of authorized COVID-19 vaccines in the context of staggered arrival of vaccine supply.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply","revision_id":"bf3682a2-d342-4e51-8805-9e1beb4a70a2"}